Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for FOXM1_TBL1XR1
Z-value: 1.16
Motif logo
Transcription factors associated with FOXM1_TBL1XR1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
FOXM1
|
ENSG00000111206.8 | forkhead box M1 |
|
TBL1XR1
|
ENSG00000177565.11 | TBL1X receptor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| FOXM1 | hg19_v2_chr12_-_2986107_2986258 | 0.07 | 6.9e-01 | Click! |
| TBL1XR1 | hg19_v2_chr3_-_176914238_176914277 | -0.05 | 8.0e-01 | Click! |
Activity profile of FOXM1_TBL1XR1 motif
Sorted Z-values of FOXM1_TBL1XR1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr7_-_142247606 | 2.72 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
| chr8_-_7274385 | 2.65 |
ENST00000318157.2
|
DEFB4B
|
defensin, beta 4B |
| chr19_-_51472823 | 2.31 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr8_+_7752151 | 2.24 |
ENST00000302247.2
|
DEFB4A
|
defensin, beta 4A |
| chr19_-_51487282 | 2.01 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
| chr1_-_158301312 | 1.95 |
ENST00000368168.3
|
CD1B
|
CD1b molecule |
| chr19_-_51456344 | 1.94 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
| chr7_+_142031986 | 1.93 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
| chr19_-_51456321 | 1.88 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
| chr4_+_159443090 | 1.80 |
ENST00000343542.5
ENST00000470033.1 |
RXFP1
|
relaxin/insulin-like family peptide receptor 1 |
| chr19_-_51456198 | 1.73 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
| chr19_-_51472031 | 1.67 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr2_+_102928009 | 1.66 |
ENST00000404917.2
ENST00000447231.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
| chr5_+_96211643 | 1.62 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
| chr3_+_19189946 | 1.62 |
ENST00000328405.2
|
KCNH8
|
potassium voltage-gated channel, subfamily H (eag-related), member 8 |
| chr2_-_31637560 | 1.58 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
| chrX_-_65259900 | 1.57 |
ENST00000412866.2
|
VSIG4
|
V-set and immunoglobulin domain containing 4 |
| chrX_-_63450480 | 1.57 |
ENST00000362002.2
|
ASB12
|
ankyrin repeat and SOCS box containing 12 |
| chrX_-_65259914 | 1.50 |
ENST00000374737.4
ENST00000455586.2 |
VSIG4
|
V-set and immunoglobulin domain containing 4 |
| chr19_-_51466681 | 1.48 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51471381 | 1.47 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr2_-_169746878 | 1.46 |
ENST00000282074.2
|
SPC25
|
SPC25, NDC80 kinetochore complex component |
| chr14_-_105420241 | 1.44 |
ENST00000557457.1
|
AHNAK2
|
AHNAK nucleoprotein 2 |
| chr2_-_119605253 | 1.43 |
ENST00000295206.6
|
EN1
|
engrailed homeobox 1 |
| chr13_-_46756351 | 1.42 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
| chr7_-_122339162 | 1.41 |
ENST00000340112.2
|
RNF133
|
ring finger protein 133 |
| chr11_-_123756334 | 1.39 |
ENST00000528595.1
ENST00000375026.2 |
TMEM225
|
transmembrane protein 225 |
| chr2_-_158345462 | 1.38 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
| chr19_-_51893827 | 1.34 |
ENST00000574814.1
|
CTD-2616J11.4
|
chromosome 19 open reading frame 84 |
| chrX_+_49296814 | 1.33 |
ENST00000420398.2
|
GAGE12C
|
G antigen 12C |
| chr19_-_51471362 | 1.32 |
ENST00000376853.4
ENST00000424910.2 |
KLK6
|
kallikrein-related peptidase 6 |
| chr12_-_8218997 | 1.31 |
ENST00000307637.4
|
C3AR1
|
complement component 3a receptor 1 |
| chr12_-_8815299 | 1.31 |
ENST00000535336.1
|
MFAP5
|
microfibrillar associated protein 5 |
| chr8_+_134203303 | 1.30 |
ENST00000519433.1
ENST00000517423.1 ENST00000377863.2 ENST00000220856.6 |
WISP1
|
WNT1 inducible signaling pathway protein 1 |
| chr16_+_3405889 | 1.27 |
ENST00000304936.2
|
OR2C1
|
olfactory receptor, family 2, subfamily C, member 1 |
| chr6_-_32784687 | 1.24 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
| chr12_-_71182695 | 1.24 |
ENST00000342084.4
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R |
| chr4_+_156588115 | 1.23 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr4_-_156787425 | 1.23 |
ENST00000537611.2
|
ASIC5
|
acid-sensing (proton-gated) ion channel family member 5 |
| chr1_-_153085984 | 1.23 |
ENST00000468739.1
|
SPRR2F
|
small proline-rich protein 2F |
| chrX_-_65253506 | 1.22 |
ENST00000427538.1
|
VSIG4
|
V-set and immunoglobulin domain containing 4 |
| chr6_-_25830785 | 1.22 |
ENST00000468082.1
|
SLC17A1
|
solute carrier family 17 (organic anion transporter), member 1 |
| chr19_+_6135646 | 1.22 |
ENST00000588304.1
ENST00000588485.1 ENST00000588722.1 ENST00000591403.1 ENST00000586696.1 ENST00000589401.1 ENST00000252669.5 |
ACSBG2
|
acyl-CoA synthetase bubblegum family member 2 |
| chr16_+_57023406 | 1.22 |
ENST00000262510.6
ENST00000308149.7 ENST00000436936.1 |
NLRC5
|
NLR family, CARD domain containing 5 |
| chr5_-_147211226 | 1.21 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr5_-_101834712 | 1.18 |
ENST00000506729.1
ENST00000389019.3 ENST00000379810.1 |
SLCO6A1
|
solute carrier organic anion transporter family, member 6A1 |
| chr5_+_96212185 | 1.17 |
ENST00000379904.4
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
| chr2_+_102608306 | 1.17 |
ENST00000332549.3
|
IL1R2
|
interleukin 1 receptor, type II |
| chr4_+_156587979 | 1.16 |
ENST00000511507.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr20_-_7921090 | 1.16 |
ENST00000378789.3
|
HAO1
|
hydroxyacid oxidase (glycolate oxidase) 1 |
| chr5_-_147211190 | 1.16 |
ENST00000510027.2
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr12_+_75874580 | 1.16 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr18_+_45778672 | 1.13 |
ENST00000600091.1
|
AC091150.1
|
HCG1818186; Uncharacterized protein |
| chr11_-_58343319 | 1.12 |
ENST00000395074.2
|
LPXN
|
leupaxin |
| chr1_+_117297007 | 1.11 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
| chr6_+_127898312 | 1.11 |
ENST00000329722.7
|
C6orf58
|
chromosome 6 open reading frame 58 |
| chr1_-_205391178 | 1.10 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
| chr12_+_75874984 | 1.10 |
ENST00000550491.1
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr11_-_5323226 | 1.10 |
ENST00000380224.1
|
OR51B4
|
olfactory receptor, family 51, subfamily B, member 4 |
| chr13_-_103389159 | 1.09 |
ENST00000322527.2
|
CCDC168
|
coiled-coil domain containing 168 |
| chr3_-_195538760 | 1.08 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
| chr5_-_101834617 | 1.08 |
ENST00000513675.1
ENST00000379807.3 |
SLCO6A1
|
solute carrier organic anion transporter family, member 6A1 |
| chr10_-_86001210 | 1.08 |
ENST00000372105.3
|
LRIT1
|
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1 |
| chr7_+_28725585 | 1.07 |
ENST00000396298.2
|
CREB5
|
cAMP responsive element binding protein 5 |
| chr8_+_67405755 | 1.07 |
ENST00000521495.1
|
C8orf46
|
chromosome 8 open reading frame 46 |
| chrX_-_73072534 | 1.07 |
ENST00000429829.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
| chr13_+_77522632 | 1.07 |
ENST00000377462.1
|
IRG1
|
immunoresponsive 1 homolog (mouse) |
| chr20_-_55100981 | 1.06 |
ENST00000243913.4
|
GCNT7
|
glucosaminyl (N-acetyl) transferase family member 7 |
| chr6_-_22297730 | 1.06 |
ENST00000306482.1
|
PRL
|
prolactin |
| chrX_+_49216659 | 1.06 |
ENST00000415752.1
|
GAGE12I
|
G antigen 12I |
| chr6_-_3195981 | 1.06 |
ENST00000425384.2
ENST00000435043.2 |
RP1-40E16.9
|
RP1-40E16.9 |
| chr4_+_156588249 | 1.05 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr12_-_8815215 | 1.05 |
ENST00000544889.1
ENST00000543369.1 |
MFAP5
|
microfibrillar associated protein 5 |
| chr12_+_56075330 | 1.05 |
ENST00000394252.3
|
METTL7B
|
methyltransferase like 7B |
| chr1_-_238649319 | 1.04 |
ENST00000400946.2
|
RP11-371I1.2
|
long intergenic non-protein coding RNA 1139 |
| chr11_+_61008514 | 1.04 |
ENST00000312403.5
|
PGA5
|
pepsinogen 5, group I (pepsinogen A) |
| chr4_-_110723134 | 1.03 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
| chr17_-_29641084 | 1.02 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
| chr5_-_158526756 | 1.02 |
ENST00000313708.6
ENST00000517373.1 |
EBF1
|
early B-cell factor 1 |
| chr3_+_149191723 | 1.02 |
ENST00000305354.4
|
TM4SF4
|
transmembrane 4 L six family member 4 |
| chr12_-_11175219 | 1.01 |
ENST00000390673.2
|
TAS2R19
|
taste receptor, type 2, member 19 |
| chr4_-_159956333 | 1.01 |
ENST00000434826.2
|
C4orf45
|
chromosome 4 open reading frame 45 |
| chrX_+_49363665 | 1.00 |
ENST00000381700.6
|
GAGE1
|
G antigen 1 |
| chr10_+_118187379 | 0.99 |
ENST00000369230.3
|
PNLIPRP3
|
pancreatic lipase-related protein 3 |
| chr7_-_41740181 | 0.99 |
ENST00000442711.1
|
INHBA
|
inhibin, beta A |
| chr2_+_89975669 | 0.98 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
| chr1_+_172422026 | 0.98 |
ENST00000367725.4
|
C1orf105
|
chromosome 1 open reading frame 105 |
| chr10_+_7745303 | 0.98 |
ENST00000429820.1
ENST00000379587.4 |
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chr15_+_84906338 | 0.98 |
ENST00000512109.1
|
GOLGA6L4
|
golgin A6 family-like 4 |
| chr7_-_69062391 | 0.98 |
ENST00000436600.2
|
RP5-942I16.1
|
RP5-942I16.1 |
| chr9_+_12693336 | 0.97 |
ENST00000381137.2
ENST00000388918.5 |
TYRP1
|
tyrosinase-related protein 1 |
| chr14_+_73563735 | 0.96 |
ENST00000532192.1
|
RBM25
|
RNA binding motif protein 25 |
| chr8_+_66955648 | 0.95 |
ENST00000522619.1
|
DNAJC5B
|
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
| chr21_+_27011899 | 0.95 |
ENST00000425221.2
|
JAM2
|
junctional adhesion molecule 2 |
| chr6_-_35992270 | 0.94 |
ENST00000394602.2
ENST00000355574.2 |
SLC26A8
|
solute carrier family 26 (anion exchanger), member 8 |
| chr12_+_8975061 | 0.93 |
ENST00000299698.7
|
A2ML1
|
alpha-2-macroglobulin-like 1 |
| chr18_-_10787140 | 0.93 |
ENST00000383408.2
|
PIEZO2
|
piezo-type mechanosensitive ion channel component 2 |
| chr12_-_10251603 | 0.92 |
ENST00000457018.2
|
CLEC1A
|
C-type lectin domain family 1, member A |
| chr3_-_112218205 | 0.92 |
ENST00000383680.4
|
BTLA
|
B and T lymphocyte associated |
| chr2_-_169769787 | 0.92 |
ENST00000451987.1
|
SPC25
|
SPC25, NDC80 kinetochore complex component |
| chr12_-_11139511 | 0.92 |
ENST00000506868.1
|
TAS2R50
|
taste receptor, type 2, member 50 |
| chr1_-_20446020 | 0.91 |
ENST00000375105.3
|
PLA2G2D
|
phospholipase A2, group IID |
| chr8_+_118147498 | 0.91 |
ENST00000519688.1
ENST00000456015.2 |
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8 |
| chr1_-_153113927 | 0.90 |
ENST00000368752.4
|
SPRR2B
|
small proline-rich protein 2B |
| chr3_-_186080012 | 0.90 |
ENST00000544847.1
ENST00000265022.3 |
DGKG
|
diacylglycerol kinase, gamma 90kDa |
| chr4_-_77328458 | 0.90 |
ENST00000388914.3
ENST00000434846.2 |
CCDC158
|
coiled-coil domain containing 158 |
| chr7_+_141811539 | 0.90 |
ENST00000550469.2
ENST00000477922.3 |
RP11-1220K2.2
|
Putative inactive maltase-glucoamylase-like protein LOC93432 |
| chr3_-_195538728 | 0.89 |
ENST00000349607.4
ENST00000346145.4 |
MUC4
|
mucin 4, cell surface associated |
| chr1_+_87595433 | 0.89 |
ENST00000469312.2
ENST00000490006.2 |
RP5-1052I5.1
|
long intergenic non-protein coding RNA 1140 |
| chr6_+_22221010 | 0.89 |
ENST00000567753.1
|
RP11-524C21.2
|
RP11-524C21.2 |
| chr6_-_105585022 | 0.89 |
ENST00000314641.5
|
BVES
|
blood vessel epicardial substance |
| chr1_-_47407097 | 0.88 |
ENST00000457840.2
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11 |
| chr4_+_156588350 | 0.88 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr4_-_110723335 | 0.88 |
ENST00000394634.2
|
CFI
|
complement factor I |
| chr9_-_39239171 | 0.88 |
ENST00000358144.2
|
CNTNAP3
|
contactin associated protein-like 3 |
| chr9_-_21368075 | 0.86 |
ENST00000449498.1
|
IFNA13
|
interferon, alpha 13 |
| chr7_-_37024665 | 0.86 |
ENST00000396040.2
|
ELMO1
|
engulfment and cell motility 1 |
| chr1_+_248031277 | 0.85 |
ENST00000537741.1
|
OR2W3
|
olfactory receptor, family 2, subfamily W, member 3 |
| chr11_+_127140956 | 0.85 |
ENST00000608214.1
|
RP11-480C22.1
|
RP11-480C22.1 |
| chr10_+_48355024 | 0.85 |
ENST00000395702.2
ENST00000442001.1 ENST00000433077.1 ENST00000436850.1 ENST00000494156.1 ENST00000586537.1 |
ZNF488
|
zinc finger protein 488 |
| chr20_-_1638360 | 0.85 |
ENST00000216927.4
ENST00000344103.4 |
SIRPG
|
signal-regulatory protein gamma |
| chr1_-_156571254 | 0.85 |
ENST00000438976.2
ENST00000334588.7 ENST00000368232.4 ENST00000415314.2 |
GPATCH4
|
G patch domain containing 4 |
| chr19_-_57988871 | 0.85 |
ENST00000596831.1
ENST00000601768.1 ENST00000356584.3 ENST00000600175.1 ENST00000425074.3 ENST00000343280.4 ENST00000427512.2 |
AC004076.9
ZNF772
|
Uncharacterized protein zinc finger protein 772 |
| chr6_-_11779840 | 0.84 |
ENST00000506810.1
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
| chr4_-_110723194 | 0.84 |
ENST00000394635.3
|
CFI
|
complement factor I |
| chr6_-_25874440 | 0.83 |
ENST00000361703.6
ENST00000397060.4 |
SLC17A3
|
solute carrier family 17 (organic anion transporter), member 3 |
| chr2_+_133874577 | 0.83 |
ENST00000596384.1
|
AC011755.1
|
HCG2006742; Protein LOC100996685 |
| chr12_-_8043736 | 0.83 |
ENST00000539924.1
|
SLC2A14
|
solute carrier family 2 (facilitated glucose transporter), member 14 |
| chr1_+_154293584 | 0.83 |
ENST00000324978.3
ENST00000484864.1 |
AQP10
|
aquaporin 10 |
| chr14_-_70546897 | 0.82 |
ENST00000394330.2
ENST00000533541.1 ENST00000216568.7 |
SLC8A3
|
solute carrier family 8 (sodium/calcium exchanger), member 3 |
| chr4_+_88896819 | 0.82 |
ENST00000237623.7
ENST00000395080.3 ENST00000508233.1 ENST00000360804.4 |
SPP1
|
secreted phosphoprotein 1 |
| chr3_-_123411191 | 0.82 |
ENST00000354792.5
ENST00000508240.1 |
MYLK
|
myosin light chain kinase |
| chr2_-_113594279 | 0.82 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
| chr8_-_27115931 | 0.82 |
ENST00000523048.1
|
STMN4
|
stathmin-like 4 |
| chr13_+_111766897 | 0.81 |
ENST00000317133.5
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
| chr9_-_21305312 | 0.81 |
ENST00000259555.4
|
IFNA5
|
interferon, alpha 5 |
| chr4_+_156587853 | 0.81 |
ENST00000506455.1
ENST00000511108.1 |
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr1_-_150208320 | 0.81 |
ENST00000534220.1
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
| chr6_+_123100853 | 0.81 |
ENST00000356535.4
|
FABP7
|
fatty acid binding protein 7, brain |
| chr11_-_64739358 | 0.81 |
ENST00000301896.5
ENST00000530444.1 |
C11orf85
|
chromosome 11 open reading frame 85 |
| chr2_-_65090754 | 0.81 |
ENST00000445865.1
|
AC007880.1
|
AC007880.1 |
| chr19_+_12862604 | 0.80 |
ENST00000553030.1
|
BEST2
|
bestrophin 2 |
| chr20_-_1638408 | 0.80 |
ENST00000303415.3
ENST00000381583.2 |
SIRPG
|
signal-regulatory protein gamma |
| chr5_-_158526693 | 0.80 |
ENST00000380654.4
|
EBF1
|
early B-cell factor 1 |
| chr12_+_51236703 | 0.80 |
ENST00000551456.1
ENST00000398458.3 |
TMPRSS12
|
transmembrane (C-terminal) protease, serine 12 |
| chr1_-_247921982 | 0.80 |
ENST00000408896.2
|
OR1C1
|
olfactory receptor, family 1, subfamily C, member 1 |
| chr11_-_102651343 | 0.80 |
ENST00000279441.4
ENST00000539681.1 |
MMP10
|
matrix metallopeptidase 10 (stromelysin 2) |
| chr10_-_75401500 | 0.80 |
ENST00000359322.4
|
MYOZ1
|
myozenin 1 |
| chr2_-_18770812 | 0.80 |
ENST00000359846.2
ENST00000304081.4 ENST00000600945.1 ENST00000532967.1 ENST00000444297.2 |
NT5C1B
NT5C1B-RDH14
|
5'-nucleotidase, cytosolic IB NT5C1B-RDH14 readthrough |
| chr19_-_38397285 | 0.79 |
ENST00000303868.5
|
WDR87
|
WD repeat domain 87 |
| chr11_+_5474638 | 0.79 |
ENST00000341449.2
|
OR51I2
|
olfactory receptor, family 51, subfamily I, member 2 |
| chr11_-_59952106 | 0.79 |
ENST00000529054.1
ENST00000530839.1 |
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
| chr20_+_58179582 | 0.78 |
ENST00000371015.1
ENST00000395639.4 |
PHACTR3
|
phosphatase and actin regulator 3 |
| chr6_+_31540056 | 0.78 |
ENST00000418386.2
|
LTA
|
lymphotoxin alpha |
| chr22_-_37403839 | 0.78 |
ENST00000402860.3
ENST00000381821.1 |
TEX33
|
testis expressed 33 |
| chr10_+_97733786 | 0.78 |
ENST00000371198.2
|
CC2D2B
|
coiled-coil and C2 domain containing 2B |
| chr4_-_107957454 | 0.78 |
ENST00000285311.3
|
DKK2
|
dickkopf WNT signaling pathway inhibitor 2 |
| chr22_-_37403858 | 0.77 |
ENST00000405091.2
|
TEX33
|
testis expressed 33 |
| chr1_-_153029980 | 0.77 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
| chr16_+_8807419 | 0.77 |
ENST00000565016.1
ENST00000567812.1 |
ABAT
|
4-aminobutyrate aminotransferase |
| chr4_+_100432161 | 0.76 |
ENST00000326581.4
ENST00000514652.1 |
C4orf17
|
chromosome 4 open reading frame 17 |
| chr1_+_144989309 | 0.75 |
ENST00000596396.1
|
AL590452.1
|
Uncharacterized protein |
| chr1_-_160492994 | 0.75 |
ENST00000368055.1
ENST00000368057.3 ENST00000368059.3 |
SLAMF6
|
SLAM family member 6 |
| chr22_-_30866564 | 0.75 |
ENST00000435069.1
ENST00000415957.2 ENST00000540910.1 |
SEC14L3
|
SEC14-like 3 (S. cerevisiae) |
| chr19_-_52148798 | 0.75 |
ENST00000534261.2
|
SIGLEC5
|
sialic acid binding Ig-like lectin 5 |
| chr11_+_6226782 | 0.74 |
ENST00000316375.2
|
C11orf42
|
chromosome 11 open reading frame 42 |
| chr12_-_95945246 | 0.74 |
ENST00000258499.3
|
USP44
|
ubiquitin specific peptidase 44 |
| chr12_+_75874460 | 0.74 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chrX_+_122318113 | 0.74 |
ENST00000371264.3
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3 |
| chr1_-_207143802 | 0.74 |
ENST00000324852.4
ENST00000400962.3 |
FCAMR
|
Fc receptor, IgA, IgM, high affinity |
| chr4_-_138453606 | 0.73 |
ENST00000412923.2
ENST00000344876.4 ENST00000507846.1 ENST00000510305.1 |
PCDH18
|
protocadherin 18 |
| chr12_-_8693469 | 0.73 |
ENST00000545274.1
ENST00000446457.2 |
CLEC4E
|
C-type lectin domain family 4, member E |
| chr14_+_21525981 | 0.73 |
ENST00000308227.2
|
RNASE8
|
ribonuclease, RNase A family, 8 |
| chr11_+_5410607 | 0.73 |
ENST00000328611.3
|
OR51M1
|
olfactory receptor, family 51, subfamily M, member 1 |
| chr7_+_150264365 | 0.73 |
ENST00000255945.2
ENST00000461940.1 |
GIMAP4
|
GTPase, IMAP family member 4 |
| chr12_-_10251576 | 0.73 |
ENST00000315330.4
|
CLEC1A
|
C-type lectin domain family 1, member A |
| chr6_+_25754927 | 0.73 |
ENST00000377905.4
ENST00000439485.2 |
SLC17A4
|
solute carrier family 17, member 4 |
| chr3_+_46412345 | 0.73 |
ENST00000292303.4
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene) |
| chr1_-_157811588 | 0.72 |
ENST00000368174.4
|
CD5L
|
CD5 molecule-like |
| chr11_-_114466471 | 0.72 |
ENST00000424261.2
|
NXPE4
|
neurexophilin and PC-esterase domain family, member 4 |
| chr11_-_3663212 | 0.72 |
ENST00000397067.3
|
ART5
|
ADP-ribosyltransferase 5 |
| chr9_-_72435576 | 0.71 |
ENST00000453410.1
ENST00000526458.1 ENST00000439418.1 |
C9orf135-AS1
|
C9orf135 antisense RNA 1 (head to head) |
| chr2_-_118943930 | 0.71 |
ENST00000449075.1
ENST00000414886.1 ENST00000449819.1 |
AC093901.1
|
AC093901.1 |
| chr19_-_38397228 | 0.71 |
ENST00000447313.2
|
WDR87
|
WD repeat domain 87 |
| chr11_+_63304273 | 0.71 |
ENST00000439013.2
ENST00000255688.3 |
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3 |
| chr19_-_51487071 | 0.71 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
| chr12_-_11548496 | 0.71 |
ENST00000389362.4
ENST00000565533.1 ENST00000546254.1 |
PRB2
PRB1
|
proline-rich protein BstNI subfamily 2 proline-rich protein BstNI subfamily 1 |
| chr15_-_22448819 | 0.71 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
| chr2_-_89545079 | 0.70 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
| chr11_+_60989688 | 0.70 |
ENST00000378149.3
ENST00000422676.2 |
PGA4
|
pepsinogen 4, group I (pepsinogen A) |
| chr13_-_45992541 | 0.70 |
ENST00000522438.1
|
SLC25A30
|
solute carrier family 25, member 30 |
| chr1_+_45205498 | 0.70 |
ENST00000372218.4
|
KIF2C
|
kinesin family member 2C |
| chr8_+_36641842 | 0.70 |
ENST00000523973.1
ENST00000399881.3 |
KCNU1
|
potassium channel, subfamily U, member 1 |
| chr12_-_8814669 | 0.70 |
ENST00000535411.1
ENST00000540087.1 |
MFAP5
|
microfibrillar associated protein 5 |
| chr22_+_19467261 | 0.70 |
ENST00000455750.1
ENST00000437685.2 ENST00000263201.1 ENST00000404724.3 |
CDC45
|
cell division cycle 45 |
| chr1_+_244515930 | 0.69 |
ENST00000366537.1
ENST00000308105.4 |
C1orf100
|
chromosome 1 open reading frame 100 |
| chr3_-_190167571 | 0.69 |
ENST00000354905.2
|
TMEM207
|
transmembrane protein 207 |
| chr21_+_27011584 | 0.69 |
ENST00000400532.1
ENST00000480456.1 ENST00000312957.5 |
JAM2
|
junctional adhesion molecule 2 |
| chr4_-_80247162 | 0.69 |
ENST00000286794.4
|
NAA11
|
N(alpha)-acetyltransferase 11, NatA catalytic subunit |
| chr11_+_58695174 | 0.69 |
ENST00000317391.4
|
GLYATL1
|
glycine-N-acyltransferase-like 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of FOXM1_TBL1XR1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 8.3 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.9 | 5.3 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.6 | 0.6 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
| 0.5 | 2.1 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.5 | 1.9 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.5 | 1.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
| 0.5 | 1.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.4 | 1.8 | GO:2000685 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.4 | 9.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.4 | 2.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.4 | 1.3 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.4 | 1.6 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.4 | 1.6 | GO:0061743 | motor learning(GO:0061743) |
| 0.4 | 0.8 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.4 | 1.1 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.4 | 1.1 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
| 0.4 | 2.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.3 | 1.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.3 | 3.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.3 | 1.0 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.3 | 2.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.3 | 0.9 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.3 | 0.3 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.3 | 0.9 | GO:0038185 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.3 | 1.7 | GO:0072564 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 0.3 | 0.3 | GO:0051781 | positive regulation of cell division(GO:0051781) |
| 0.3 | 1.1 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
| 0.3 | 0.8 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.3 | 0.8 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.3 | 0.8 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.3 | 1.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.3 | 1.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.3 | 1.0 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
| 0.3 | 1.0 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.2 | 1.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.2 | 0.7 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.2 | 0.7 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 0.2 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.2 | 1.0 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.2 | 0.7 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.2 | 0.9 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.2 | 2.3 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.2 | 3.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.2 | 1.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 0.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 | 0.7 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.2 | 0.7 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 0.2 | 0.7 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.2 | 0.9 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.2 | 1.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.2 | 2.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 | 0.6 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.2 | 0.2 | GO:1903487 | regulation of lactation(GO:1903487) |
| 0.2 | 0.6 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.2 | 0.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.2 | 0.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.2 | 0.2 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.2 | 1.0 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 0.2 | 0.4 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.2 | 0.2 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 0.2 | 0.8 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.2 | 2.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.2 | 0.4 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.2 | 1.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.2 | 4.7 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.2 | 0.8 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 | 2.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.2 | 0.2 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
| 0.2 | 0.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.2 | 0.7 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.2 | 0.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.2 | 1.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.2 | 0.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.2 | 0.2 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.2 | 0.5 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.2 | 0.2 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.2 | 0.9 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.2 | 0.5 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.2 | 0.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.2 | 2.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.2 | 0.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 | 0.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 | 0.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.2 | 0.7 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 | 0.2 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
| 0.2 | 0.5 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.2 | 0.7 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.2 | 0.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.2 | 1.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.2 | 0.2 | GO:1900229 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.2 | 1.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.2 | 0.2 | GO:0060711 | labyrinthine layer development(GO:0060711) |
| 0.2 | 0.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.2 | 0.3 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.2 | 0.5 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.2 | 1.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.2 | 0.3 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
| 0.2 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.2 | 0.2 | GO:0086013 | membrane repolarization during action potential(GO:0086011) membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
| 0.2 | 0.8 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.2 | 1.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 | 1.1 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.2 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.2 | 0.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.2 | 1.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 0.5 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.2 | 0.9 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 0.2 | 2.0 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 | 0.2 | GO:1903970 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 0.2 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 | 0.4 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.1 | 0.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.1 | 0.9 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 | 0.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 | 0.6 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.1 | 0.7 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.1 | 0.9 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 0.4 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.1 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
| 0.1 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.1 | 0.6 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.1 | 0.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 | 1.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 0.4 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.1 | 0.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 0.8 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.1 | 0.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.1 | 1.3 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
| 0.1 | 1.5 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.1 | 0.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.1 | 0.4 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 | 1.1 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.1 | 0.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.1 | 2.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 0.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 1.0 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 | 0.5 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 0.1 | 2.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.3 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.1 | 0.5 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.1 | 0.1 | GO:0001656 | metanephros development(GO:0001656) |
| 0.1 | 0.3 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
| 0.1 | 0.4 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.1 | 1.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 0.5 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.1 | 0.2 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.1 | 0.9 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.1 | 2.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.1 | 0.7 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.1 | 0.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 | 2.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 1.4 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.8 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.1 | 0.4 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.1 | 1.4 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.1 | 0.4 | GO:0019860 | uracil metabolic process(GO:0019860) |
| 0.1 | 0.4 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
| 0.1 | 0.5 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.1 | 0.5 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.1 | 0.2 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.1 | 0.1 | GO:2001183 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.1 | 0.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 | 2.3 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.1 | 0.7 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
| 0.1 | 0.1 | GO:0048663 | neuron fate commitment(GO:0048663) |
| 0.1 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 0.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.1 | 0.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 0.1 | GO:0002221 | pattern recognition receptor signaling pathway(GO:0002221) |
| 0.1 | 1.0 | GO:0001554 | luteolysis(GO:0001554) |
| 0.1 | 0.3 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.1 | 1.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
| 0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
| 0.1 | 0.1 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.1 | 0.3 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.1 | 1.0 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.3 | GO:0051300 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.1 | 1.0 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.1 | GO:2000665 | interleukin-13 secretion(GO:0072611) regulation of interleukin-13 secretion(GO:2000665) |
| 0.1 | 1.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.1 | 0.8 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 | 0.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.1 | 0.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.1 | 0.8 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 0.7 | GO:1904044 | response to aldosterone(GO:1904044) |
| 0.1 | 0.2 | GO:0050673 | epithelial cell proliferation(GO:0050673) |
| 0.1 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.1 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.4 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 | 0.8 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.1 | 0.3 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.1 | 0.5 | GO:2000468 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
| 0.1 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.1 | 1.5 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 | 0.3 | GO:0034241 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.1 | 0.2 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.1 | 0.8 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.1 | 0.8 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.1 | 0.5 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.1 | 0.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 | 0.3 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.1 | 0.5 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.1 | 0.3 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.1 | 0.3 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 | 0.3 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.1 | 0.5 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.1 | 0.4 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 | 0.5 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
| 0.1 | 0.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 0.3 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 | 1.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.1 | 0.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.1 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 0.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.1 | 0.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 | 0.7 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.1 | 0.1 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 | 0.4 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
| 0.1 | 0.3 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.1 | 0.4 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.1 | 0.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.1 | 1.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 | 1.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
| 0.1 | 0.8 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.1 | 0.3 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 | 0.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 | 0.3 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.1 | 0.4 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.1 | 0.6 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 | 0.3 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.1 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.1 | 3.9 | GO:0097435 | fibril organization(GO:0097435) |
| 0.1 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
| 0.1 | 1.6 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 | 0.2 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.1 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.8 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 | 0.2 | GO:0098907 | regulation of SA node cell action potential(GO:0098907) |
| 0.1 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
| 0.1 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 | 0.4 | GO:0010269 | response to selenium ion(GO:0010269) |
| 0.1 | 1.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.1 | 0.2 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 0.1 | 0.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 0.3 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.1 | 0.5 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.1 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.1 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 0.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
| 0.1 | 0.2 | GO:1903978 | regulation of microglial cell activation(GO:1903978) |
| 0.1 | 0.1 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
| 0.1 | 0.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 | 0.1 | GO:0007320 | insemination(GO:0007320) |
| 0.1 | 0.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.1 | 0.2 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.1 | 0.2 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.1 | 0.2 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.1 | 0.2 | GO:0006547 | histidine metabolic process(GO:0006547) |
| 0.1 | 0.1 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 0.2 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.1 | 0.6 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
| 0.1 | 0.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.1 | 1.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.1 | 0.2 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.1 | 0.1 | GO:0048263 | determination of dorsal identity(GO:0048263) |
| 0.1 | 0.9 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.1 | 0.3 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.1 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
| 0.1 | 0.2 | GO:0021545 | cranial nerve development(GO:0021545) |
| 0.1 | 0.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.2 | GO:0042704 | uterine wall breakdown(GO:0042704) |
| 0.1 | 2.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 | 1.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.1 | 0.3 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.1 | 0.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
| 0.1 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.1 | 0.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 | 0.1 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.1 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.1 | 0.3 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.1 | 0.4 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 0.1 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.1 | 1.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 0.1 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.1 | 0.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.1 | 0.2 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.1 | 0.2 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 | 0.1 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.1 | 0.2 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.1 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 0.1 | 0.6 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 | 0.2 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 0.1 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 | 1.4 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
| 0.1 | 0.1 | GO:0042391 | regulation of membrane potential(GO:0042391) |
| 0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 0.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 | 0.3 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
| 0.1 | 0.4 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 | 0.1 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
| 0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
| 0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 0.1 | GO:2000670 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.1 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
| 0.1 | 0.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.1 | 0.3 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
| 0.1 | 0.1 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 0.1 | 0.2 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 0.1 | 0.3 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
| 0.1 | 0.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
| 0.1 | 0.1 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 0.1 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 0.1 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.1 | 0.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.1 | 1.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 | 0.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.1 | 0.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.6 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.1 | 0.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.1 | 1.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.1 | 0.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.1 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.1 | 0.2 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.1 | 0.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 0.1 | 0.3 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.1 | 0.6 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.1 | 0.6 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.1 | 0.1 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.1 | 0.2 | GO:0090260 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.1 | 6.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.1 | 0.1 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.1 | 0.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 0.4 | GO:0034486 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
| 0.1 | 0.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 0.1 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 0.1 | 0.1 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.1 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 | 0.8 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.1 | 0.1 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.1 | 0.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.1 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 | 0.2 | GO:0002027 | regulation of heart rate(GO:0002027) |
| 0.1 | 0.2 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.1 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 | 0.4 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.1 | 0.3 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.1 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.1 | 0.2 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.1 | 0.2 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.1 | 0.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.1 | 0.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.1 | 0.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 | 0.2 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 0.1 | 0.1 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 | 0.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 | 0.2 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 0.2 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.1 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 | 0.7 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 0.1 | GO:0045444 | fat cell differentiation(GO:0045444) |
| 0.1 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.1 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.1 | 0.2 | GO:1901909 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 0.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 0.1 | 0.2 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.1 | 0.1 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) metanephric proximal tubule development(GO:0072237) |
| 0.1 | 1.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 0.2 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.1 | 0.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.1 | 0.2 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
| 0.1 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 0.2 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.1 | 0.2 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.1 | 0.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.1 | 0.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 | 0.3 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 0.1 | 0.1 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.1 | 0.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 1.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 | 0.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.1 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
| 0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 | 0.1 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.1 | 0.3 | GO:0006311 | meiotic gene conversion(GO:0006311) |
| 0.1 | 0.2 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 0.1 | 0.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 0.1 | 0.2 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.1 | 0.7 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.1 | 0.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.1 | 0.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 | 0.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.1 | 0.3 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 0.2 |